This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19.
New England Journal of Medicine:2022: August 18 Full text
Antibody therapy reverses biological signatures of COVID-19 progression.
Cell Reports Medicine:2022: August 16 Full text
Pathophysiology and Epidemiology
Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study.
BMJ:2022: August 2 Full text
Rash morphology as a predictor of COVID‐19 severity: A systematic review of the cutaneous manifestations of COVID‐19. SVHA
Skin Health and Disease:2022: May 12 Full text
Long Covid
Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity.
Open Forum Infectious Diseases:2022: August 4 Full text
Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
Clinical Infectious Diseases:2022: August 12 Full text
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Lancet Psychiatry:2022: August 17 Full text
Vaccines
Durability of heterologous and homologous COVID-19 vaccine boosts.
JAMA Network Open:2022: August 10 Full text
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study.
Lancet Rheumatology:2022: August 16 Full text
Tolerability of COVID-19 infection and messenger RNA vaccination among patients with a history of Kawasaki Disease.
JAMA Network Open:2022: August 12 Full text
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine.
Science Translational Medicine:2022: August 17 Full text
Immunology
Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Lancet Respiratory Medicine:2022: August 18 Full text
Antibody response in immunocompromised patients with hematologic cancers who received a 3-dose mRNA-1273 vaccination schedule for COVID-19.
JAMA Oncology:2022: August 11 Full text
